Position in AVXL
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$590,507
+$120,779 QoQ
Shares Held
227,995
+49.0% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2
of 13 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Apella Capital, LLC holds $7,226,690 across 7 Biotechnology names. AVXL ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DRTS |
Alpha Tau Medical Ltd.
|
382,284 | $4,809,132 | |
| 2 | CLDX |
Celldex Therapeutics, Inc.
|
26,658 | $991,944 | |
| 3 | AVXL |
Anavex Life Sciences Corp.
This page
|
227,995 | $590,507 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
603 | $299,528 | |
| 5 | NERV |
Minerva Neurosciences, Inc.
|
42,250 | $234,487 | |
| 6 | PGEN |
Precigen, Inc.
|
28,985 | $165,214 | |
| 7 | OMER |
Omeros Corp
|
14,288 | $135,878 |
All Filings in AVXL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $590,507 | 227,995 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $469,728 | 153,006 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $491,301 | 138,006 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $885,763 | 99,524 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $908,677 | 98,555 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $845,601 | 98,555 | Shares | Sole | 2025-04-10 | |
| 2022-09-30 | $104,232 | 10,100 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $101,101 | 10,100 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $124,331 | 10,100 | Shares | Sole | 2022-04-11 | |
| No filing history on record for this holder in this stock. | ||||||